Ashley Atkins, MSN, APRN, FNP-C
Ashley Atkins works directly with patients throughout the consultation and follow-up process.
Weight loss is personal. Your medical history, previous experiences, medications, daily habits, and health goals all matter. Our Florida telehealth practice provides personalized medical weight-loss consultations for eligible adults. When medically appropriate, your provider may discuss prescription options such as semaglutide or tirzepatide. Medication is not guaranteed, and no single option is right for every patient. Your care begins with a consultation and an individual medical review.
Many patients have already tried diets, exercise plans, tracking apps, or other approaches before requesting medical support.
At Restore MD, we begin by learning about you.
Ashley Atkins, MSN, APRN, FNP-C works directly with patients to understand their health history, previous weight-loss experiences, current medications, concerns, and personal goals. She is supported by Dr. Jon Kimball and Dr. Paige Lindberg, a husband-and-wife physician team.
Together, the providers evaluate whether medical weight-loss support may be appropriate and which options should be considered.
We are not an open medication storefront. New patients cannot select semaglutide, tirzepatide, or another prescription medication without first completing an appropriate consultation and medical review.
Medical weight loss is a provider-guided approach to weight management.
Rather than offering the same plan to every patient, your provider considers your individual health information and determines which forms of support may be medically appropriate.
A medical weight-loss plan may include prescription medication, nutrition guidance, activity recommendations, behavioral support, and ongoing medical follow-up.
The exact plan varies by patient.
Patients seek medical weight-loss support for many different reasons. You may want to speak with a provider if:
You have struggled to lose weight despite making changes
You have repeatedly lost and regained weight
Hunger or food cravings make it difficult to stay consistent
Your weight is affecting how you feel physically
You have questions about GLP-1 medications
You previously used a weight-loss medication
You are unsure whether semaglutide or tirzepatide may be appropriate
You want medical oversight rather than purchasing medication online
You would like a plan built around your health history
These concerns do not automatically mean that you qualify for prescription medication.
A licensed provider will determine whether medical weight-loss therapy may be appropriate based on your complete evaluation.
GLP-1 is a hormone involved in appetite, digestion, and blood-sugar regulation.
Certain medications act on GLP-1 pathways and may help reduce appetite or help patients feel full longer. These medications are prescription therapies and should be used only under appropriate medical supervision.
FDA-approved semaglutide and tirzepatide products are available for chronic weight management in certain adults with obesity or overweight and an additional weight-related condition. They are intended to be used along with nutrition and physical-activity changes.
Your provider will determine whether one of these medications, another option, or a non-medication approach may be appropriate.
Semaglutide and tirzepatide are different prescription medications. They should not be treated as interchangeable products.
Both may be considered for eligible patients, but they work through somewhat different hormone pathways. The appropriate choice depends on the patient’s health history, current medications, goals, insurance coverage, medication availability, and the provider’s medical judgment.
Semaglutide acts on the GLP-1 receptor.
Wegovy is an FDA-approved semaglutide product used for chronic weight management in qualifying patients. Other semaglutide brand names may have different FDA-approved uses.
Your provider will determine whether an FDA-approved semaglutide product is appropriate and available for you.
Tirzepatide acts on both GIP and GLP-1 receptors.
Zepbound is an FDA-approved tirzepatide product used for chronic weight management in qualifying adults. Tirzepatide is also sold under another brand name for type 2 diabetes, which has a different approved use.
Your provider will determine whether an FDA-approved tirzepatide product is appropriate and available for you.
Your provider will explain the potential benefits, risks, side effects, limitations, and alternatives that apply to your situation.
The strongest telehealth weight-loss programs combine provider care with practical support instead of presenting medication as the entire solution.
Your personalized plan may address four connected areas:
Your provider reviews your health history, current medications, previous experiences, and possible risk factors.
Semaglutide, tirzepatide, or another prescription option may be considered when medically appropriate.
Nutrition, movement, sleep, hydration, and other routines may influence your experience and progress.
Follow-Up Support: Your provider may monitor progress, laboratory results, medication tolerance, concerns, and possible side effects. The practice should list only the nutrition, coaching, behavioral, and lifestyle services it has confirmed that it can provide.
Eligibility depends on the specific medication and the individual patient.
Certain FDA-approved weight-management medications are indicated for adults with obesity or for some adults with overweight who also have a weight-related medical condition. These definitions are commonly based partly on body mass index, but BMI does not provide a complete picture of a patient’s health.
Do not begin, stop, combine, or change weight-loss medications without
speaking with a licensed provider.
No. Semaglutide and tirzepatide are not appropriate for every patient.
Each medication has its own prescribing information, warnings, possible side effects, and situations in which it should not be used.
Your provider will review the considerations that apply to the specific medication being discussed. You should tell your provider about all medical conditions, medications, supplements, allergies, previous reactions, and pregnancy plans.
Some patients experience digestive side effects while using GLP-1-based medications. Your provider should explain what to expect, when to contact the practice, and when urgent medical care may be needed.
Eligibility and results vary by patient.
The practice should clearly tell patients whether the specific medication being discussed is FDA-approved or compounded.
FDA-approved products have been evaluated by the FDA for safety, effectiveness, and manufacturing quality for their approved uses.
Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
In 2026, the FDA continued to raise concerns about mass-marketed, non-FDA-approved semaglutide and tirzepatide products. The agency reported fraudulent labeling, dosing errors, and products falsely associated with pharmacies that did not prepare them.
Before therapy begins, patients should receive clear information about:
The medication name
The active ingredient
Whether it is FDA-approved or compounded
The prescribing provider
The dispensing or compounding pharmacy
How the medication should be used
How it should be stored
Follow-up and monitoring
How to report concerns or side effects
Internal note before publication:
Confirm whether Restore MD offers FDA-approved branded medication, compounded medication for individual patient needs, or both. Do not imply that a compounded product is a generic or identical version of an FDA-approved product.
Your provider may order laboratory testing based on your health history, current medications, and the medical plan being considered.
When testing is ordered, you will receive a laboratory requisition that can be taken to an approved laboratory, such as Labcorp or another registered laboratory. A licensed provider will review your available results and consider them alongside your medical history, weight history, medications, and goals.
There is no single laboratory panel that is right for every patient.
Complete the consultation request and tell us what you would like to discuss.
Provide information about your weight history, medical conditions, medications, previous weight-loss efforts, and goals.
Discuss your concerns through a secure telehealth consultation.
Your provider may order blood work or request additional medical information.
When medically appropriate, your provider may discuss semaglutide, tirzepatide, another medication, or a non-medication approach.
Follow-up may include virtual consultations, medication reviews, laboratory monitoring, progress discussions, and appropriate plan adjustments.
Not every patient will require medication or laboratory testing.
Medical weight loss is an ongoing process. Follow-up appointments give your provider an opportunity to:
Review how you are feeling
Discuss medication tolerance
Review possible side effects
Evaluate progress
Answer questions
Review laboratory results when applicable
Discuss nutrition and activity habits
Determine whether the plan remains appropriate
Make adjustments when medically necessary
Discuss maintenance planning
You should not increase, decrease, skip, combine, or restart medication without following your provider’s instructions.
The frequency and format of follow-up care vary by patient.
Our telehealth model allows eligible patients throughout Florida to speak with a licensed medical provider from home.
Through secure virtual consultations, you may be able to:
Discuss your weight and health goals
Review previous weight-loss efforts
Discuss semaglutide and tirzepatide
Review current medications
Receive laboratory testing instructions
Review laboratory results
Discuss possible side effects
Complete eligible follow-up visits
Review whether your plan remains appropriate
Patients must be located in Florida when receiving care from the practice. Providers must hold the appropriate Florida license or telehealth registration.
Ashley Atkins is the primary patient-facing provider. She is supported by Dr. Jon Kimball and Dr. Paige Lindberg.
New patients complete a medical review before prescription medication is considered.
Your provider considers your health history, medications, previous experiences, goals, and laboratory results when available.
Patients should understand which medication is being prescribed, its approval status, and where it will be dispensed.
The practice currently serves eligible patients located in Florida.
Follow-up may include progress reviews, medication monitoring, laboratory testing, and appropriate adjustments.
Requesting a consultation does not guarantee that semaglutide, tirzepatide, or another medication will be prescribed.
Start with a personalized consultation and take the next step with a qualified medical team.
Ashley Atkins works directly with patients throughout the consultation and follow-up process.
Dr. Jon Kimball supports the practice as part of the medical team.
Dr. Jon Kimball is a Board Certified Orthopedic and Spine Surgeon who specializes in the treatment of patients suffering from chronic pain.
Dr. Paige Lindberg works alongside Dr. Jon Kimball as part of the practice’s husband-and-wife physician team.
Medical weight loss is a provider-guided approach that considers your health history, weight history, current medications, goals, and possible prescription options.
The plan may include medication, lifestyle guidance, laboratory testing, and follow-up care.
Semaglutide is a prescription medication that acts on the GLP-1 receptor.
Wegovy is an FDA-approved semaglutide product for chronic weight management in qualifying patients. Your provider will determine whether it may be appropriate.
Tirzepatide is a prescription medication that acts on both GIP and GLP-1 receptors.
Zepbound is an FDA-approved tirzepatide product for chronic weight management in qualifying adults.
No. Tirzepatide and semaglutide are different active ingredients that act on different hormone pathways.
Your provider will determine which option, if any, may be appropriate.
Results differ based on the medication, dose, health history, adherence, lifestyle factors, and the individual patient.
The practice should not recommend a medication based only on average weight-loss percentages. Your provider will consider the complete medical picture.
No. Requesting a consultation does not guarantee a prescription.
A licensed provider must determine whether medication is medically appropriate.
Not necessarily. Certain semaglutide and tirzepatide products are FDA-approved specifically for chronic weight management in qualifying patients, including some patients who do not have diabetes.
Eligibility depends on the specific medication and the patient’s medical evaluation.
Possibly. Your provider will determine whether laboratory testing is appropriate based on your health history and the plan being considered.
No. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing.
Patients should receive clear information about whether a medication is compounded and where it was prepared.
No. New patients must complete an appropriate consultation and medical review before prescription medication can be considered.
The patient portal is for established patients managing eligible refills, reorders, documents, and practice communications.
Eligible patients located in Florida may be able to complete consultations and appropriate follow-up visits through telehealth.
Laboratory testing may still need to be completed at an approved laboratory.
The length of therapy varies by patient and medication.
Your provider will review your progress, tolerance, health needs, and maintenance options before recommending changes.
Contact the practice according to the instructions provided by your medical team.
Seek urgent or emergency care when your symptoms require immediate attention.
Ashley Atkins, MSN, APRN, FNP-C is the primary patient-facing provider. She is supported by Dr. Jon Kimball and Dr. Paige Lindberg.
Begin by requesting an initial consultation. Our team will review your request and explain the next appropriate step.
You may already have questions about semaglutide or tirzepatide, or you may simply want to understand whether medical weight-loss support is right for you.
Tell us about your health, your previous experiences, and what you hope to accomplish.
A licensed provider will review your information and help determine which next step may be appropriate.